Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · BlackRock Health Sciences Trust (BME)

BlackRock Health Sciences Trust signs standstill agreement with Saba Capital through 2027

Neutral Impact 3 of 5 shareholder Written later

On January 20, 2025, BlackRock Health Sciences Trust and its investment advisor entered into a standstill agreement with Saba Capital Management, L.P. Under the agreement, Saba agrees to follow customary standstill covenants and to vote any of its common shares in line with the Board of Trustees' recommendation. The agreement runs until the day after the Fund's 2027 annual shareholder meeting or August 31, 2027, whichever comes first, unless ended earlier.

Key points

  • Agreement dated January 20, 2025, with Saba Capital Management, L.P.
  • Saba agrees to customary standstill covenants and to vote its shares, if any, per the Board's recommendation
  • Term ends the day after the 2027 annual meeting or August 31, 2027, whichever is earlier

The filing

CompanyBlackRock Health Sciences Trust (BME)
Form8-K, current report
Filed with the SECJan 21, 2025, 8:51 AM ET
Accession number0001193125-25-009173

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.